AROUND 2 MILLION PEOPLE IN THE U.S. ARE LIVING WITH SEVERE ASTHMA.WITH THE SEASON CHANGING AND DIFFERENT WEATHER PATTERNS ON ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

To inform clinicians on the best biologic agent for different populations of adults with severe asthma, 12 experts collaborated on a new clinical practice guideline published in CHEST, according to a ...

Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Please provide your email address to receive an email when new articles are posted on . The Severe Asthma Index assesses how nations address severe asthma. Results indicate a need to recognize severe ...

—A new study from Sweden assesses the prevalence of severe asthma, highlighting the impact of the disease in this population at a time when promising new treatments are entering the market. Reviewed ...

A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. A landmark ...

Real-world data from 2016 to 2025 highlight the changing landscape of biologic use and the growing preference for tezepelumab in asthma.

Asthma isn’t always a quick and easy diagnosis in children. According to a 2014 task force assembled by the American Thoracic Society and the European Respiratory Society, pediatric severe asthma can ...

Mackenzie Sinclair was walking through a bustling Melbourne Central last spring when she realised she could no longer breathe ...

Recent updates on severe asthma include real-world data on triggers, efficacy of benralizumab and dupilumab, and the approval of Tezspire as add-on maintenance treatment. Read the latest updates on ...

Not all asthma is the same. Asthma UK estimates there are 5.4 million people in the UK who live with the disease, mostly with mild to moderate forms. But at the other end of the spectrum, there are ...